z-logo
open-access-imgOpen Access
Impact of add-back FSH on human and mouse prostate following gonadotropin ablation by GnRH antagonist treatment
Author(s) -
Eleftherios E. Deiktakis,
Eleftheria Ieronymaki,
Peter Zarén,
Agnes Hagsund,
Elin Wirestrand,
Johan Malm,
Christos Tsatsanis,
Ilpo Huhtaniemi,
Aleksander Giwercman,
Yvonne Lundberg Giwercman
Publication year - 2022
Publication title -
endocrine connections
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.941
H-Index - 23
ISSN - 2049-3614
DOI - 10.1530/ec-21-0639
Subject(s) - flutamide , endocrinology , medicine , testosterone (patch) , prostate , luteinizing hormone , prostate cancer , follicle stimulating hormone , gonadotropin releasing hormone antagonist , androgen , gonadotropin , hormone , gonadotropin releasing hormone , androgen receptor , cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom